| Котировки и графики в реальном времени | Новости | Фундаментальные показатели | Компания | Добавить | |
|---|---|---|---|---|---|
| Котировки и график | Ход торгов | Новости | Оценки | Календарь | В портфель |
| Последние сделки | Прогнозы аналитиков | Дивиденды | Профиль | В список наблюдения | |
| Биржи | Целевые цены | Баланс | |||
| Архив торгов | |||||
| Название | Доля (%) |
|---|---|
| Freefloat | 99,98 |
| SSgA Funds Management, Inc. | 4,99 |
| 235 East 42nd Street, 10017-5755 New York | |
| а/я: | |
| Телефон: | +1 (212) 733-2323 |
| Факс: | |
| Вэб: | http://www.pfizer.com |
| Albert Bourla Chairman, Chief Executive & Operating Officer |
| Aamir Malik Chief Business Innovation Officer & Executive VP |
| Sally Susman Chief Corporate Affairs Officer & Executive VP |
| William Pao Chief Development Officer & Executive VP |
| Brenda Cooperstone Chief Development Officer & Senior Vice President |
| David M. Denton Chief Financial Officer & Executive Vice President |
| Mike McDermott Chief Global Supply Officer & Executive VP |
| Payal Sahni Becher Chief Human Resources Officer & Executive VP |
| Aida Habtezion Chief Medical Officer |
| Mikael Dolsten Chief Scientific Officer & Research President |
| Donna Wartski Dir-Med Outcomes Specialist, US Medical Affairs |
| Susan D. Desmond-Hellmann Director |
| Denis Patrick Executive Director |
| Maritza C. McIntyre Executive Director-Gene Therapy Product Lead |
| Rady A. Johnson Executive VP, Chief Compliance & Risk Officer |
| Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer |
| Douglas M. Lankler Executive Vice President & General Counsel |
| Suneet Varma Global President-Rare Diseases |
| Angela Hwang Group President-Biopharmaceuticals |
| David DeMicco Head-Medical Affairs, Global Innovative Products |
| Dan R. Littman Independent Director |
| Susan J. Hockfield Independent Director |
| Ronald E. Blaylock Independent Director |
| Joseph J. Echevarria Independent Director |
| James C. Smith Independent Director |
| James Quincey Independent Director |
| Suzanne Nora Johnson Independent Director |
| Helen H. Hobbs Independent Director |
| Bryan Dunn Investor Relations Contact |
| Shantanu Narayen Lead Independent Director |
| Scott Gottlieb Member of the Board of Directors |
| Andy Schmeltz President-US Oncology Business Unit |
| Margaret M. Madden Secretary, Chief Governance Counsel & Senior VP |
| Jennifer B. Damico Senior VP-Controller & Accounting Officer |
| Deborah Baron Senior VP-Worldwide Business Development |
| Christopher J. Stevo Senior Vice President |
| Gordon Loh Senior Vice President-Corporate Audit |
| Annaliesa Anderson VP, Head-Vaccine Research & Development |
| Markus Green Vice President & Assistant General Counsel |
| Hakan Sakul Vice President & Head-Diagnostics |
| Eva Grut-Aandahl Vice President, Head of EU Government Affairs |
| Barbara J. Dalton Vice President-Worldwide Business Development |
| John DeYoung Vice President-Worldwide Business Development |